Mutual Of America Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Mutual Of America Capital Management LLC

$9.32 Billion
Q3 2024

A detailed history of Mutual Of America Capital Management LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 5,780 shares of RARE stock, worth $273,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,780

Holding current value

$273,740

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$40.21 - $59.36 $232,413 - $343,100	5,780 New	5,780 $321,000
Q2 2022 Aug 10, 2022	SELL	$45.8 - $85.4 $1.47 Million - $2.74 Million	-32,089 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$62.2 - $84.4 $79,118 - $107,356	-1,272 Reduced 3.81%	32,089 $2.33 Million
Q4 2021 Feb 03, 2022	SELL	$73.71 - $87.86 $21,007 - $25,040	-285 Reduced 0.85%	33,361 $2.81 Million
Q3 2021 Nov 10, 2021	BUY	$77.92 - $102.4 $181,943 - $239,104	2,335 Added 7.46%	33,646 $3.04 Million
Q2 2021 Aug 06, 2021	SELL	$92.19 - $115.71 $869,536 - $1.09 Million	-9,432 Reduced 23.15%	31,311 $2.99 Million
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $240,952 - $378,063	-2,254 Reduced 5.24%	40,743 $4.64 Million
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $76,550 - $160,892	-907 Reduced 2.07%	42,997 $5.95 Million
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $805,407 - $993,240	11,036 Added 33.58%	43,904 $3.61 Million
Q2 2020 Aug 06, 2020	SELL	$46.91 - $78.22 $146,359 - $244,046	-3,120 Reduced 8.67%	32,868 $2.57 Million
Q1 2020 May 11, 2020	SELL	$33.8 - $62.9 $52,187 - $97,117	-1,544 Reduced 4.11%	35,988 $1.6 Million
Q4 2019 Feb 11, 2020	SELL	$36.08 - $45.83 $9,092 - $11,549	-252 Reduced 0.67%	37,532 $1.6 Million
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $8,712 - $12,937	-205 Reduced 0.54%	37,784 $1.62 Million
Q2 2019 Aug 12, 2019	BUY	$54.93 - $74.36 $1,373 - $1,859	25 Added 0.07%	37,989 $2.41 Million
Q1 2019 May 13, 2019	BUY	$39.87 - $69.36 $26,752 - $46,540	671 Added 1.8%	37,964 $2.63 Million
Q4 2018 Feb 12, 2019	BUY	$38.89 - $77.3 $5,833 - $11,595	150 Added 0.4%	37,293 $1.62 Million
Q3 2018 Nov 13, 2018	SELL	$71.81 - $90.15 $37,125 - $46,607	-517 Reduced 1.37%	37,143 $2.84 Million
Q2 2018 Aug 09, 2018	SELL	$48.54 - $85.31 $12,135 - $21,327	-250 Reduced 0.66%	37,660 $2.9 Million
Q1 2018 May 11, 2018	BUY	$44.33 - $58.52 $24,381 - $32,186	550 Added 1.47%	37,910 $1.93 Million
Q4 2017 Jan 31, 2018	SELL	$43.54 - $57.32 $6,400 - $8,426	-147 Reduced 0.39%	37,360 $1.73 Million
Q3 2017 Oct 18, 2017	BUY	$49.79 - $66.32 $1.87 Million - $2.49 Million	37,507	37,507 $2 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.32B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Account

Mutual Of America Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History